Unverified50% confidenceFactExact time
The U.S. FDA has established a regulatory framework for AI/ML-based medical device software, and as of 2024 has approved or cleared more than 900 AI-driven medical devices.
1
Sources
50%
Confidence
Medium-term (~90 days)
Relevance
9/1/2026
First Seen
Valid until: 11/30/2026
Sources
Related Entities
Related Claims
UnverifiedFDA在2021年发布的《基于AI/ML的软件即医疗器械行动计划》中特别强调了算法透明度和实际性能监控的重要性79% similarUnverified美国FDA在2021年发布《人工智能/机器学习医疗器械软件行动计划》，要求通过510(k)或PMA流程；欧盟MDR（2017/745法规）于2021年正式生效；中国NMPA于2021年发布《人工智能医疗器械注册审查指导原则》79% similarUnverifiedThe US FDA published the "Artificial Intelligence/Machine Learning-Based Software as a Medical Device Action Plan" in 2021, introducing the concept of a Predetermined Change Control Plan.78% similarUnverified2023年FDA发布了AI/ML药物开发讨论文件，但仅是初步探索75% similarUnverified美国FDA已于2023年发布专项指南，认可合成医疗数据在特定条件下的监管有效性74% similar
Cite This Claim
Stable URI
https://kongchang.com/claim/837382API
curl https://kongchang.com/api/v1/knowledge/claims/837382MCP
get_claim(id=837382)